1.
Practical Considerations for the Use of Tapentadol Prolonged Release for the Management of Severe Chronic Pain
by Sánchez del Águila, Manuel J., FCARCSI
Clinical therapeutics, 2015, Vol.37 (1), p.94-113
2.
Efficacy and tolerability of tapentadol immediate release and oxycodone HCl immediate release in patients awaiting primary joint replacement surgery for end-stage joint disease: A...
by Hartrick, Craig, MD
Clinical therapeutics, 2009, Vol.31 (2), p.260-271
3.
Long-term Safety and Efficacy of Tapentadol Extended Release Following up to 2 Years of Treatment in Patients With Moderate to Severe, Chronic Pain: Results of an Open-label Extens...
by Buynak, Robert, MD
Clinical therapeutics, 2015, Vol.37 (11), p.2420-2438
4.
Impact of Prolonged-release Oxycodone/Naloxone on Outcomes Affecting Patients' Daily Functioning in Comparison With Extended-release Tapentadol: A Systematic Review
by Thakur, Deepika, MPharm
Clinical therapeutics, 2015, Vol.37 (1), p.212-224
5.
Cost-Effectiveness of Tapentadol in Severe Chronic Pain in Spain: A Cost Analysis of Data From RCTs
by Obradovic, Marko, PhD
Clinical therapeutics, 2012, Vol.34 (4), p.926-943
6.
Budget Impact Analysis of Tapentadol Extended Release for the Treatment of Moderate to Severe Chronic Noncancer Pain
by Merchant, Sanjay, PhD
Clinical therapeutics, 2013, Vol.35 (5), p.659-672
7.
Cost-effectiveness analysis of tapentadol immediate release for the treatment of acute pain
by Kwong, W. Jacqueline, PharmD, PhD
Clinical therapeutics, 2010, Vol.32 (10), p.1768-1781
8.
Lapatinib: A dual inhibitor of human epidermal growth factor receptor tyrosine kinases
by Medina, Patrick J., PharmD, BCOP
Clinical therapeutics, 2008, Vol.30 (8), p.1426-1447
9.
Dasatinib: A tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia and philadelphia chromosome—positive acute lymphoblastic leukemia
by Steinberg, Michael, PharmD, BCOP
Clinical therapeutics, 2007, Vol.29 (11), p.2289-2308
10.
Real-world Analysis of Tyrosine Kinase Inhibitor Treatment Patterns Among Patients With Chronic Myeloid Leukemia in the United States
by Henk, Henry J., PhD
Clinical therapeutics, 2015, Vol.37 (1), p.124-133
11.
Capsaicin 8% Patch Versus Oral Neuropathic Pain Medications for the Treatment of Painful Diabetic Peripheral Neuropathy: A Systematic Literature Review and Network Meta-analysis
by van Nooten, Floortje, MSc
Clinical therapeutics, 2017, Vol.39 (4), p.787-803.e18
12.
Magnesium Sulfate Plus Lidocaine Reduces Propofol Injection Pain: A Double-blind, Randomized Study
by Sun, Jiehao, MD
Clinical therapeutics, 2016, Vol.38 (1), p.31-38
13.
A Review of the Clinical Efficacy and Safety of Insulin Degludec and Glargine 300 U/mL in the Treatment of Diabetes Mellitus
by Woo, Vincent C., MD, FRCPC
Clinical therapeutics, 2017, Vol.39 (8), p.S12-S33
14.
Selective Serotonin Reuptake Inhibitors Versus Tricyclic Antidepressants in Young Patients: A Meta-analysis of Efficacy and Acceptability
by Qin, Bin, MD
Clinical therapeutics, 2014, Vol.36 (7), p.1087-1095.e4
15.
Estradiol Valerate/Dienogest: A Novel Combined Oral Contraceptive
by Borgelt, Laura M., PharmD
Clinical therapeutics, 2012, Vol.34 (1), p.37-55
16.
Results of a retrospective claims database analysis of differences in antidepressant treatment persistence associated with escitalopram and other selective serotonin reuptake inhib...
by Esposito, Dominick, PhD
Clinical therapeutics, 2009, Vol.31 (3), p.644-656
17.
Nilotinib: A second-generation tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia
by DeRemer, David L., PharmD, BCOP
Clinical therapeutics, 2008, Vol.30 (11), p.1956-1975
18.
Open-label, prospective, randomized comparison of propofol and sevoflurane for laryngeal mask anesthesia for magnetic resonance imaging in pediatric patients
by Ozdemir Kol, Iclal, MD
Clinical therapeutics, 2008, Vol.30 (1), p.175-181
19.
Dopamine and Dobutamine Use in Preterm or Low Birth Weight Neonates in the Premier 2008 Database
by Lasky, Tamar, PhD
Clinical therapeutics, 2011, Vol.33 (12), p.2082-2088
20.
A comparison of pretreatment with fentanyl and lidocaine preceded by venous occlusion for reducing pain on injection of propofol: A prospective, randomized, double-blind, placebo-c...
by Fujii, Yoshitaka, MD
Clinical therapeutics, 2009, Vol.31 (10), p.2107-2112
